US equities |
MU $1,035.84 ▼-4.79% NVDA $230.48 ▼-2.94% SNDK $1,609.46 ▼-4.90% AMD $620.68 ▼-3.90% INTC $107.08 ▼-5.34% AAPL $340.42 ▲+1.11% META $720.89 ▼-0.06% SPCX $160.57 ▼-4.19%
FinancialContent

Latest News about Citius Pharmaceuticals

Recent news which mentions Citius Pharmaceuticals

Citius Pharmaceuticals Approaches End Of Trial For Catheter-Related Bloodstream Infections – How Are Analysts Scoring Its Stock?
Tickers CRMD CTXR ZVRA
Tags Market News CTXR CRMD
From Benzinga
Citius Pharmaceuticals Moving Forward With Spin Out Efforts For New Public Company For I/ONTAK
Tags Biotech Benzinga General
From Benzinga
Citius Pharmaceuticals Addresses Unmet Needs for Patients with CVCs
Tickers CTXR
Tags Markets Market News News
From Benzinga